New pharmacological agents and emerging therapeutic targets for painful diabetic neuropathy
Painful diabetic peripheral neuropathy (PDPN) remains a serious complication of diabetes mellitus (DM). Recent clinical trials have demonstrated promising outcomes for pilavapadin (LX9211), an orally administered selective, potent inhibitor of adapter protein-2-associated kinase 1 (AAK1) and vixotri...
Shranjeno v:
| Principais autores: | , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Frontiers Media S.A.
2026-03-01
|
| Serija: | Frontiers in Endocrinology |
| Teme: | |
| Online dostop: | https://www.frontiersin.org/articles/10.3389/fendo.2026.1788702/full |
| Oznake: |
Brez oznak, prvi označite!
|